BG101602A - Pharmaceutical piperazine compounds - Google Patents

Pharmaceutical piperazine compounds

Info

Publication number
BG101602A
BG101602A BG101602A BG10160297A BG101602A BG 101602 A BG101602 A BG 101602A BG 101602 A BG101602 A BG 101602A BG 10160297 A BG10160297 A BG 10160297A BG 101602 A BG101602 A BG 101602A
Authority
BG
Bulgaria
Prior art keywords
group
value
nco2r11
c6alkyl
alkenyl
Prior art date
Application number
BG101602A
Other languages
Bulgarian (bg)
English (en)
Inventor
Philip ASHWORTH
Sukhjit Hunjan
Ian PRETSWELL
Hamish Rider
Stephen Brocchini
Original Assignee
Xenova Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Limited filed Critical Xenova Limited
Publication of BG101602A publication Critical patent/BG101602A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG101602A 1994-12-23 1997-06-11 Pharmaceutical piperazine compounds BG101602A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9426224.3A GB9426224D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds
PCT/GB1995/003027 WO1996020190A1 (en) 1994-12-23 1995-12-22 Piperazine 2,5 dione derivatives as modulators of multi-drug resistance

Publications (1)

Publication Number Publication Date
BG101602A true BG101602A (en) 1998-02-27

Family

ID=10766589

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101602A BG101602A (en) 1994-12-23 1997-06-11 Pharmaceutical piperazine compounds

Country Status (19)

Country Link
EP (1) EP0799222A1 (cs)
JP (1) JPH10511384A (cs)
CN (1) CN1175253A (cs)
AU (1) AU698828B2 (cs)
BG (1) BG101602A (cs)
BR (1) BR9510410A (cs)
CA (1) CA2207500A1 (cs)
CZ (1) CZ190097A3 (cs)
FI (1) FI972660A7 (cs)
GB (1) GB9426224D0 (cs)
HU (1) HUT77943A (cs)
IL (1) IL116525A0 (cs)
NO (1) NO972937L (cs)
NZ (1) NZ297847A (cs)
PL (1) PL320916A1 (cs)
SK (1) SK83697A3 (cs)
TW (1) TW358094B (cs)
WO (1) WO1996020190A1 (cs)
ZA (1) ZA9510909B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9717576D0 (en) 1997-08-19 1997-10-22 Xenova Ltd Pharmaceutical compounds
HUP0001531A3 (en) * 1996-10-18 2000-09-28 Xenova Ltd Slough Anthranilic acid derivatives as multi drug resistance modulators
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
IL142388A0 (en) 1998-10-08 2002-03-10 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
JP4810043B2 (ja) * 2000-01-18 2011-11-09 ネリアス・ファーマシュティカルズ・インコーポレーテッド 細胞分裂阻害剤及びその製造方法
AU2001288829A1 (en) 2000-09-06 2002-03-22 Ap Pharma, Inc. Degradable polyacetal polymers
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
DK1529044T5 (da) 2002-08-02 2008-04-21 Nereus Pharmaceuticals Inc Dehydrophenylahistiner og analoger deraf og syntesen af dehydrophenylahistiner og analoger deraf
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
CN103396372B (zh) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用
HK1249052A1 (zh) 2015-03-06 2018-10-26 BeyondSpring Pharmaceuticals Inc. 治疗与ras突变相关的癌症的方法
EP3265091A4 (en) 2015-03-06 2018-08-01 Beyondspring Pharmaceuticals Inc. Method of treating a brain tumor
MX376122B (es) 2015-07-13 2025-03-07 Beyondspring Pharmaceuticals Inc Composiciones de plinabulina.
SG11201806583XA (en) 2016-02-08 2018-09-27 Beyondspring Pharmaceuticals Inc Compositions containing tucaresol or its analogs
BR112018074990A2 (pt) 2016-06-06 2019-03-12 Beyondspring Pharmaceuticals, Inc. composição, usos e método para reduzir neutropenia
US11633393B2 (en) 2017-01-06 2023-04-25 Beyondspring Pharmaceuticals, Inc. Tubulin binding compounds and therapeutic use thereof
EP3576733A4 (en) 2017-02-01 2020-11-25 Beyondspring Pharmaceuticals, Inc. NEUTROPENIA REDUCTION METHOD
KR20200112881A (ko) 2018-01-24 2020-10-05 비욘드스프링 파마수티컬스, 인코포레이티드. 플리나불린의 투여를 통해 혈소판감소증을 감소시키는 조성물 및 방법
EP4319751A4 (en) 2021-04-09 2025-02-26 Beyondspring Pharmaceuticals, Inc. THERAPEUTIC COMPOSITIONS AND METHODS FOR THE TREATING OF TUMORS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69310367T2 (de) * 1992-07-10 1997-08-14 Glaxo Lab Sa Anilide-derivate
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
NZ297847A (en) 1999-04-29
CN1175253A (zh) 1998-03-04
AU698828B2 (en) 1998-11-05
PL320916A1 (en) 1997-11-10
JPH10511384A (ja) 1998-11-04
EP0799222A1 (en) 1997-10-08
WO1996020190A1 (en) 1996-07-04
FI972660A0 (fi) 1997-06-19
NO972937D0 (no) 1997-06-23
CA2207500A1 (en) 1996-07-04
CZ190097A3 (cs) 1998-01-14
HUT77943A (hu) 1998-12-28
FI972660L (fi) 1997-08-22
SK83697A3 (en) 1998-05-06
FI972660A7 (fi) 1997-08-22
AU4310096A (en) 1996-07-19
IL116525A0 (en) 1996-03-31
BR9510410A (pt) 1999-09-08
TW358094B (en) 1999-05-11
ZA9510909B (en) 1996-08-30
NO972937L (no) 1997-06-23
GB9426224D0 (en) 1995-02-22

Similar Documents

Publication Publication Date Title
BG101602A (en) Pharmaceutical piperazine compounds
BG99496A (bg) Фармацевтични съединения
BG104248A (en) Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides
TW370450B (en) Substituted 1H-3-aryl-pyrrolidine-2,4-dione derivatives
MXPA94002358A (es) Compuestos fotocromicos.
CO4970713A1 (es) Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
NZ330656A (en) Tricyclic compounds, their production and use
BG103663A (en) 4-(3-heterocyclyl-1-benzoyl)pyrazols and their application as herbicides
TW268046B (cs)
EP0211272A3 (en) Azo compound and colored composition containing same
IE802684L (en) Quinoline derivatives
GB1393263A (en) Fluorescent dyes
ES455074A1 (es) Procedimiento para la preparacion de compuestos de 3-indolil-3-bis-aminofenilftalida.
TW362954B (en) Stabilized composition, method for using said composition, and medium containing said
GB1142309A (en) Improved urea derivatives and their use as herbicides
ES473455A1 (es) Procedimiento para la preparacion de benzopiranotiazoles
DE3468104D1 (en) New aryloxypropanolamine derivatives, process for the preparation thereof, pharmaceutical compositions and therapeutic use
ES458422A1 (es) Procedimiento para la preparacion de compuestos azometini- cos.
AU4726089A (en) Benzoxazepine derivative
GB1499181A (en) Dyes for thermoplastics
WO2002072540A3 (en) Improved methods of ortho alkylation
AU633355B2 (en) Pyran-containing phthalides
AU2670084A (en) N-sulphenylated phenethylsulphonamides
WO2000071785A3 (en) 2-cylcoalkylcarbonylcyclohexane-1,3-dione derivatives as herbicides
EP1116486A4 (en) MEDICAL COMPOSITION CONTAINING NITROETHENAMINE DERIVATIVES OR SALTS AS ACTIVE INGREDIENTS